Loading...
•
Jun 30, 2024
Alkermes Q2 2024 Earnings Report
Alkermes reported solid execution across its business, delivering double-digit, year-over-year growth for its proprietary commercial product portfolio and robust profitability.
Key Takeaways
Alkermes reported second quarter revenues of $399.1 million. GAAP net income from continuing operations was $94.7 million, with diluted GAAP earnings per share from continuing operations of $0.55. The company reiterated its 2024 financial expectations.
Second quarter revenues were $399.1 million.
Net sales of proprietary products increased approximately 16% year-over-year.
GAAP net income from continuing operations was $94.7 million and diluted GAAP earnings per share from continuing operations was $0.55.
The company reiterated its 2024 financial expectations.
Alkermes
Alkermes
Alkermes Revenue by Segment
Revenue by Segment
VIVITROL Revenue
CapyFin.comARISTADA Revenue
CapyFin.comLYBALVI Revenue
CapyFin.com Forward Guidance
Alkermes reiterates its financial expectations for 2024, as set forth in its press release dated Feb. 15, 2024.
Revenue & Expenses
Visualization of income flow from segment revenue to net income